Jayshree Chemicals Limited (BOM:506520)
India · Delayed Price · Currency is INR 6.29
-0.41 (-6.12%)
At close: Jun 18, 2026
Jayshree Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 209.11 | 168.86 | 128.14 | 89.49 | 67.12 |
| 209.11 | 168.86 | 128.14 | 89.49 | 67.12 | |
Revenue Growth (YoY) | 23.83% | 31.78% | 43.18% | 33.34% | 980.96% |
Operations & Maintenance | - | 2.27 | 2.26 | 2.06 | 2.08 |
Selling, General & Admin | 5.39 | 5.22 | 5.42 | 6.65 | 4.52 |
Depreciation & Amortization | 0.06 | 2.58 | 2.53 | 2.53 | 2.56 |
Other Operating Expenses | 210.89 | 167.17 | 149.95 | 89.51 | 67.83 |
Total Operating Expenses | 216.34 | 177.24 | 160.16 | 100.75 | 76.99 |
Operating Income | -7.23 | -8.38 | -32.02 | -11.26 | -9.87 |
Interest Expense | -0.66 | -0.56 | -1 | -0.05 | -0 |
Interest Income | - | 6.43 | 7.57 | 11.6 | 10.08 |
Net Interest Expense | -0.66 | 5.87 | 6.57 | 11.55 | 10.08 |
Other Non-Operating Income (Expenses) | 9.61 | 1.9 | 3.84 | 1.75 | 1.23 |
EBT Excluding Unusual Items | 1.72 | -0.61 | -21.61 | 2.04 | 1.44 |
Gain (Loss) on Sale of Investments | - | 0.27 | - | 0.04 | 0.38 |
Gain (Loss) on Sale of Assets | - | -0.17 | -0.6 | -0.14 | - |
Other Unusual Items | -1.72 | -2.15 | -12.82 | -3.95 | -5.21 |
Pretax Income | -0 | -2.66 | -35.04 | -2.02 | -3.39 |
Earnings From Continuing Ops. | -0 | -2.66 | -35.04 | -2.02 | -3.39 |
Earnings From Discontinued Ops. | 3.09 | - | - | - | - |
Net Income to Company | 3.09 | -2.66 | -35.04 | -2.02 | -3.39 |
Net Income | 3.09 | -2.66 | -35.04 | -2.02 | -3.39 |
Net Income to Common | 3.09 | -2.66 | -35.04 | -2.02 | -3.39 |
Shares Outstanding (Basic) | 28 | 29 | 29 | 29 | 29 |
Shares Outstanding (Diluted) | 28 | 29 | 29 | 29 | 29 |
Shares Change (YoY) | -4.12% | - | - | - | - |
EPS (Basic) | 0.11 | -0.09 | -1.19 | -0.07 | -0.12 |
EPS (Diluted) | 0.11 | -0.09 | -1.19 | -0.07 | -0.12 |
Free Cash Flow | -13.45 | -11.53 | -6.9 | -20.54 | -28.18 |
Free Cash Flow Per Share | -0.48 | -0.39 | -0.23 | -0.70 | -0.96 |
Profit Margin | 1.48% | -1.58% | -27.34% | -2.25% | -5.05% |
Free Cash Flow Margin | -6.43% | -6.83% | -5.38% | -22.95% | -41.99% |
EBITDA | -6.46 | -5.8 | -29.5 | -8.73 | -7.32 |
EBITDA Margin | -3.09% | -3.44% | -23.02% | -9.75% | -10.90% |
D&A For EBITDA | 0.77 | 2.58 | 2.53 | 2.53 | 2.56 |
EBIT | -7.23 | -8.38 | -32.02 | -11.26 | -9.87 |
EBIT Margin | -3.46% | -4.96% | -24.99% | -12.58% | -14.71% |
Revenue as Reported | 218.71 | 177.45 | 139.56 | 102.88 | 78.81 |